SCHEDULE: Vanguard Group Discloses 5.59% Stake in Outset Medical Inc.
Beneficial Ownership Report
The Vanguard Group has reported a 5.59% beneficial ownership stake in Outset Medical Inc., holding 991,429 shares of common stock as of June 30, 2025.
Summary
- The Vanguard Group, an investment adviser based in Malvern, PA, has filed a Schedule 13G indicating beneficial ownership in Outset Medical Inc.
- As of June 30, 2025, Vanguard beneficially owns 991,429 shares of Outset Medical Inc. Common Stock.
- This ownership represents 5.59% of the total class of securities.
- Vanguard holds sole voting power over 0 shares, shared voting power over 11,217 shares, sole dispositive power over 972,310 shares, and shared dispositive power over 19,119 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance, though a significant institutional stake can be viewed as a neutral to slightly positive signal of confidence.
Positives
- The disclosure of a significant 5.59% stake by a major institutional investor like The Vanguard Group may signal institutional confidence in Outset Medical Inc.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
This Schedule 13G filing reflects a passive investment by a large asset manager, The Vanguard Group, in Outset Medical Inc., a company operating in the medical technology sector. Such filings are routine disclosures of significant ownership stakes by institutional investors who hold shares for investment purposes rather than to influence corporate control. It indicates that Outset Medical Inc. is part of Vanguard's diversified portfolio holdings.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holding by The Vanguard Group may provide a degree of confidence to existing and potential shareholders, indicating that a major investment firm sees value in Outset Medical Inc.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires the filing of this statement, indicating the reporting period end. |
| 07/29/2025 | Date the Schedule 13G statement was signed by The Vanguard Group. |
Keywords
Outset Medical Inc., Vanguard Group, Beneficial Ownership, Common Stock, SEC Filing, Schedule 13G, Institutional Investor, Medical Devices, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.